Stay updated on LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Sign up to get notified when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Footer revision updated to v3.3.4 (replacing v3.3.3); no changes to study content or page functionality were detected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2026-01-14T02:18:38.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    29 days ago
    Change Detected
    Summary
    Added a Locations section showing New York as a study site (Buffalo, NY). Removed the separate New York Locations reference and the HHS Vulnerability Disclosure entry, and updated the page revision to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T21:17:00.000Z thumbnail image
  5. Check
    57 days ago
    Change Detected
    Summary
    Page revision updated from v3.2.0 to v3.3.2; no substantive content changes observed in the study details page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:27:20.000Z thumbnail image
  6. Check
    65 days ago
    Change Detected
    Summary
    Removed the government funding lapse notice from the page, which warned that updates might not be current and that responses could be delayed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-18T06:50:47.000Z thumbnail image
  7. Check
    79 days ago
    Change Detected
    Summary
    No significant changes were detected; the page content and layout appear unchanged.
    Difference
    0.4%
    Check dated 2025-11-03T20:38:52.000Z thumbnail image
  8. Check
    108 days ago
    Change Detected
    Summary
    Updated site notice about funding-related operating status and a new v3.2.0 release; removed the previous v3.1.0 tag.
    Difference
    4%
    Check dated 2025-10-06T04:34:54.000Z thumbnail image

Stay in the know with updates to LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the LN-145 + Pembrolizumab in Transitional Cell Cancer Clinical Trial page.